Every major pharma company announced an AI partnership in the last three years. Most of them changed nothing.

The press release went out, the stock moved, and the actual R&D pipeline stayed exactly the same.

Edison Scientific just deployed Kosmos across Incyte's full pipeline. Not a pilot. Not a proof of concept. A production system that reads 1,500 papers and writes 42,000 lines of code in a single run!

The difference between this and everything that came before it: receipts. 79% reproducibility. Every conclusion traceable to a specific paper or line of code.

This is the first time I'm looking at an AI deployment in pharma and thinking: this actually changes how drugs get made. Not in theory, or in a pitch deck - but in production, right now, across an entire R&D pipeline.

If AI can compress six months of scientific work into a single day with this level of traceability, the implications for how fast treatments reach patients are massive.

Video